These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19802993)

  • 1. Renal tolerance of ceftazidime in animals.
    Capel-Edwards K; Pratt DA
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():241-5. PubMed ID: 19802993
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftazidime in patients with impaired renal function. Studies on pharmacokinetics and nephrotoxicity.
    Thurmann-Nielsen E; Walstad RA; Dahl K; Hellum KB
    J Chemother; 1989 Jul; 1(4 Suppl):534-5. PubMed ID: 16312519
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety evaluation of meropenem in animals: studies on the kidney.
    Topham JC; Murgatroyd LB; Jones DV; Goonetilleke UR; Wright J
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():287-306. PubMed ID: 2681127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical safety evaluation of ceftazidime.
    Capel-Edwards K; Losty CR; Tucker ML; Pratt DA
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():237-9. PubMed ID: 19802992
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of the functional state of kidney mitochondria in predisposition of hydronephrotic rabits to gentamicin nephrotoxicity].
    Bushma KM
    Eksp Klin Farmakol; 2008; 71(3):26-30. PubMed ID: 18652252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Individual activity of renal enzymes in the susceptibility of hydronephrotic rabbits to aminoglycoside (gentamicin) nephrotoxicity].
    Bushma KM; Bushma MI
    Eksp Klin Farmakol; 2009; 72(2):55-9. PubMed ID: 19441732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of Moringa oleifera leaves against gentamicin-induced nephrotoxicity in rabbits.
    Ouédraogo M; Lamien-Sanou A; Ramdé N; Ouédraogo AS; Ouédraogo M; Zongo SP; Goumbri O; Duez P; Guissou PI
    Exp Toxicol Pathol; 2013 Mar; 65(3):335-9. PubMed ID: 22197459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teicoplanin: renal tolerance and pharmacokinetics in rats.
    Marre R; Schulz E; Graefe H; Sack K
    J Antimicrob Chemother; 1987 Nov; 20(5):697-704. PubMed ID: 2962975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on no effect dose of tobramycin and its recovery test in rats (author's transl)].
    Kuramoto M; Ishimura Y; Morimoto J; Okubo T; Lee SY
    Jpn J Antibiot; 1975 Dec; 28(6):767-74. PubMed ID: 1195514
    [No Abstract]   [Full Text] [Related]  

  • 10. Gentamicin nephrotoxicity in the rat: influence of age and diabetes mellitus.
    Ali BH; Bashir AK; Mugamer IT; Tanira MO
    Hum Exp Toxicol; 1996 Jan; 15(1):51-55. PubMed ID: 8845210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of nephrotoxicity of beta-lactam antibiotics.
    Tune BM
    Contrib Nephrol; 1990; 83():202-7. PubMed ID: 2100712
    [No Abstract]   [Full Text] [Related]  

  • 12. Additive nephrotoxicity of cephalosporins and aminoglycosides in the rabbit.
    Bendirdjian JP; Prime DJ; Browning MC; Hsu CY; Tune BM
    J Pharmacol Exp Ther; 1981 Sep; 218(3):681-5. PubMed ID: 7264951
    [No Abstract]   [Full Text] [Related]  

  • 13. Why ceftazidime?
    Muggleton PW
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():1-3. PubMed ID: 19810166
    [No Abstract]   [Full Text] [Related]  

  • 14. Curcumin attenuates gentamicin-induced renal oxidative damage in rats.
    Farombi EO; Ekor M
    Food Chem Toxicol; 2006 Sep; 44(9):1443-8. PubMed ID: 16814915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin.
    Gautier JC; Zhou X; Yang Y; Gury T; Qu Z; Palazzi X; Léonard JF; Slaoui M; Veeranagouda Y; Guizon I; Boitier E; Filali-Ansary A; van den Berg BHJ; Poetz O; Joos T; Zhang T; Wang J; Detilleux P; Li B
    Toxicol Appl Pharmacol; 2016 Jul; 303():1-10. PubMed ID: 27105553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Sánchez-Izquierdo JA; Pedraz JL
    Chemotherapy; 2007; 53(3):194-201. PubMed ID: 17356270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats.
    Ozer MK; Asci H; Oncu M; Yesilot S; Savran M; Bayram D; Cicek E
    Ren Fail; 2009; 31(2):134-9. PubMed ID: 19212910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers.
    Keirstead ND; Wagoner MP; Bentley P; Blais M; Brown C; Cheatham L; Ciaccio P; Dragan Y; Ferguson D; Fikes J; Galvin M; Gupta A; Hale M; Johnson N; Luo W; McGrath F; Pietras M; Price S; Sathe AG; Sasaki JC; Snow D; Walsky RL; Kern G
    Toxicol Sci; 2014 Feb; 137(2):278-91. PubMed ID: 24189134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and efficacy of ceftazidime in experimental Haemophilus influenzae b meningitis.
    Krasinski K; Nelson JD
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():339-43. PubMed ID: 19803011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of ceftazidime into extracellular fluid in patients.
    Hoffstedt B; Walder M
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():289-92. PubMed ID: 19803000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.